Ledger.Open graph →
SEC Form D · filed July 15, 2019

XYNOMIC PHARMACEUTICALS HOLDINGS, INC

Offering
$15.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SHANGHAI, Israel
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Yinglin M. Xu · Shanghai, IsraelExec · DirectorWentao J. Wu · Shanghai, IsraelExecTingzhi J. Qian · Shanghai, IsraelDirectorJiayuan J. Tong · Shanghai, IsraelExec · DirectorCharles V. Prizzi · Shanghai, IsraelDirectorThomas C. Folinsbee · Shanghai, IsraelDirectorPeidong R. Wu · Shanghai, IsraelDirectorAdam R. Inglis · Shanghai, IsraelDirectorJinwei C. Kou · Shanghai, IsraelExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗